Focus On Fosamax

________________________________________________________

Free Fosamax Case Evaluation

 

The information you provide to us for this Free Case Evaluation will be treated as strictly confidential.  You will get a reply from us no later than the next business day.  Submitting a case evaluation does not obligate you to hire our law firm for your lawsuit.  We handle all cases on a contingency fee basis, which means that you will make no payment for our legal services until after we have succeeded in getting legal compensation for you.

________________________________________________________

 

My Articles About Fosamax

 

First 2015 Update On Fosamax Femur Fracture Litigation: Not Much New Information To Report Out
 
With New Jersey State Court Fosamax Lawsuits Now Assigned To Judge Mayer, We Hope These Cases Get Back On Track

SUMMARY: From Merck’s Form 10-K Annual Report For the Fiscal Year Ended December 31, 2014 we get this information about the femur fracture aspect of the Fosamax products liability litigation:

As of December 31, 2014, approximately 3,005 cases alleging Femur Fractures have been filed in New Jersey state court and are pending before Judge Jessica Mayer in Middlesex County.

Meanwhile, over at the New Jersey Courts website for the Fosamax Multicounty Litigation (accessed 3/2/15) we see some rather disappointing status information: “At this time, there are no events scheduled.”

Going back to the Merck Annual Report for 2015, we get these two additional facts from the drug company:

  • As of December 31, 2014, approximately 515 cases alleging Femur Fractures have been filed in California state court.
  • Additionally, there are four Femur Fracture cases pending in other state courts.

Hopefully in the coming months there will be some positive developments for women who suffered a Fosamax – femur fracture event and have filed a drug injury lawsuit against Merck.

[Read this article in full at original source]


Earlier Fosamax articles by Tom Lamb on the Drug Injury Watch blog
:

December 2014 Fosamax – Femur Fracture Litigation Update: In The Fosamax Federal Court MDL There Are Dismissals, Appeals, And Court-Ordered Mediations

End Of Summer 2014 Update: Fosamax – Femur Fracture Lawsuits In The New Jersey Consolidation / Multicounty Litigation

June 2014 Fosamax – Femur Fracture Litigation Update: Thousands Of Cases Pending, But No Trial Dates Currently Scheduled In Federal Court MDL Nor New Jersey Multicounty Litigation

Drug Injury Watch: Merck Faces More Than 4100 Fosamax – Femur Fracture Lawsuits As Of September 30, 2013 According To SEC Corporate Filing

Drug Injury Watch: About 1000 Pending Fosamax – Jaw Injury Lawsuits Are Subject To Judge Keenan’s August Order Remanding Cases For Trial And Disbanding The Federal Court MDL

Drug Injury Watch: Fosamax – Femur Fracture Lawsuits Filed Against Merck Said To Total 3,940 As Of June 30, 2013

Drug Injury Watch: Merck Continues To Dispute Scheinberg Fosamax Plaintiff Verdict At June 2013 Hearing Before Judge Keenan Concerning The ONJ Warnings Aspect Of Case

Drug Injury Watch: Second Fosamax – Femur Fracture Lawsuit Trial Starts In New Jersey, This One In The Federal Court MDL With Judge Pisano Presiding

Drug Injury Watch: March 2013 Fosamax Product Liability Litigation Update: Femur Fracture Cases Against Merck

Drug Injury Watch: First Fosamax – Femur Fracture Trial In New Jersey State Court Scheduled To Start March 4, 2013

Drug Injury Watch: Should Merck Have Known And Warned About Fosamax Side Effects Involving The Jaw And Femur Bone Problems Starting When This Drug Was First Put On Market In 1995

Drug Injury Watch: Atypical Femur Fractures: Due To Fosamax Or A Bisphosphonates Drug Class Side Effect?

Drug Injury Watch: January 2013 Fosamax Federal Court MDL Trial: Scheinberg vs. Merck: ONJ / Jaw Injury Case

Drug Injury Watch: Fosamax And Femur Fractures: Two New 2012 Medical Journal Articles Go From One Diagnosis To Many Long-Term Outcomes Of Patients

Drug Injury Watch: Intramedullary Nailing Surgery Is Successful Treatment For Patients With Femur Fractures From Use Of Fosamax Or Other Bisphosphonates

Drug Injury Watch: Subtrochanteric Femoral Fractures With Use Of Oral Bisphosphonates: Fosamax, Actonel, And Boniva

Drug Injury Watch: Third Boles vs. Merck Fosamax Trial In September 2012 Involves Only The Damages Amount Aspect

Drug Injury Watch: Use Of Oral Bisphosphonates Such As Boniva And Fosamax Associated With Inflammatory Eye Diseases

 

Drug Injury Watch: Fosamax Femur Fractures: Many Impending Cases Go Unrecognized By Doctors And Radiologists Due To Subtle Characteristics

 

Drug Injury Watch: New Australian Study Supports An Apparent Association Between Long-Term Fosamax Use And Certain Types Of Femur Fractures

 

Drug Injury Watch: Risk Of Femur Fractures From Osteoporosis Drugs Fosamax, Boniva, Actonel, And Reclast Related To Number Of Years Used

 

Drug Injury Watch: 1,165 Fosamax – Femur Fracture Lawsuits Pending As Of December 31, 2011 According To Merck

 

Drug Injury Watch: April 2012 Fosamax Trial Jury Verdict For Sessner v. Merck Case Expected Soon In New Jersey

 

Drug Injury Watch: Fosamax – ONJ Litigation: Sessner v. Merck Trial In New Jersey State Court: Plaintiff’s Opening Statement

 

Drug Injury Watch: Fosamax Trial In New Jersey State Court Scheduled To Start Monday, February 27, 2012

 

Drug Injury Watch: Fosamax Osteonecrosis Of The Jaw (ONJ) Federal Court MDL Litigation: A Mixed Forecast For 2012

 

Drug Injury Watch: Women Who Use Bisphosphonates Like Fosamax And Boniva Have Increased Risk Of Femur Fracture / Thigh Bone Breaks

 

Drug Injury Watch: How One Might Determine Whether The Femur Fracture Is Related To A Bisphosphonate Such As Fosamax

 

Drug Injury Watch: September 2011: Two FDA Advisory Committees Will Discuss The Safety Of Long-Term Use Of Fosamax, Boniva, And Actonel

Drug Injury Watch: Next Fosamax Jaw Injury Lawsuit Trial, Secrest v. Merck, Scheduled To Start In Early September 2011

Drug Injury Watch: Fosamax: Femur Fractures And Osteonecrosis Of Jaw: Medical Journal Articles: May 2011 Update

 

Drug Injury Watch: Fosamax Litigation: Jaw Injury And Femur Fracture Cases, Federal And NJ Courts: April 2011 Update

 

Drug Injury Watch: Thigh Bone Leg Fractures In Older Women Using Fosamax, Boniva, Or Reclast For Five Years Or More

 

Drug Injury Watch: Fosamax MDL Judge Wants Two More Bellwether Cases Selected Per February 2011 Order

 

Drug Injury Watch: First Fosamax Trial Against Merck In New Jersey State Court Starts In January 2011

 

Drug Injury Watch: Graves v. Merck Fosamax MDL Trial Begins After Pre-trial Motions Rulings By Judge Keenan

 

Drug Injury Watch: Graves v. Merck Fosamax MDL Trial Jury Verdict Is Expected By End Of November 2010

 

Drug Injury Watch: Fosamax Femur Fracture Warning Label Change By Merck Seems Likely After Task Force Report

 

Drug Injury Watch: Boles v. Merck Fosamax Trial Jury Verdict Is $8 Million For Plaintiff In June 2010

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
______________________________________________________________________________

News Regarding Fosamax

Hundreds of Fosamax lawsuits versus Merck ordered readied for trial

 

Merck Hid Fosamax’s Bone-Weakening Risks, Lawyer Contends

 

Merck hit with $285,000 verdict in Fosamax trial

 

Osteoporosis Drugs Linked to Rare Fractures

 

New Cautions About Long-Term Use of Bone Drugs

 

Osteoporosis drugs increase risk of eye disease, says Canadian study

 

Bone drugs linked to rare thigh fractures: Health Canada

 

Fordham Professor To Lead Fosamax Settlement Talks

 

Isle woman sues drugmaker after breaking thigh bone

Bones: Experts rethink long-term use of drugs

Study Finds Slight Risk of Rare Fractures From Bone Drugs
 

Revisiting Bone Drugs and Femur Fractures
 

Rare Fractures Linked To Drugs For Weak Bones
 

Bone Drugs by Merck, Roche, Novartis May Add Leg Fractures
 

Merck’s Fosamax Didn’t Cause Jaw Disease in Woman, New Jersey Jury Is Told
 

FDA considers label changes for bisphosphonates
 

Doctor files suit, says bone drug leads to breaks
 

Bone-building drugs double the risk of esophageal cancer, but the risk is still small
 

Drugmaker Merck says it will fight $8 million compensatory damages verdict in Fosamax trial

Jury orders Merck pay $8 million Fosamax damages
 

Merck wins federal Fosamax trial
 

Researchers Puzzled by Role of Osteoporosis Drug in Rare Thighbone Fractures
 

Take bisphosphonates, break a leg?
 

FDA rules out bisphosphonate, thigh fracture link
 

Fosamax Scare Causes Women to Weigh Risk of Using Bone-Loss Drug

Fosamax: Is Long Term Use of Bone Strengthening Drug Linked to Fractures?

Sudden bone breaks reported in patients taking Fosamax


Merck Loses Dismissal Bid in Third Fosamax Case

Merck loses effort to dismiss 24 Fosamax cases
 

U.S. lawsuit over Merck’s Fosamax dismissed

Fosamax Plaintiffs Lawyer: Mistrial a ‘Shock’ to Merck


Merck lawsuit over Fosamax ends in mistrial


Merck loses effort to dismiss 24 Fosamax cases
______________________________________________________________________________

 

 

More About Fosamax At Our DrugInjuryLaw.com Web Site

 

Visit the Fosamax Information page at our Drug Injury Law web site for up-to-the-date developments regarding personal injury and wrongful death lawsuits that involve Fosamax.

 

The Law Offices of Thomas J. Lamb, P.A. is handling personal injury and wrongful death lawsuits against the drug company when a person developed a thighbone (femoral or femur) fracture after using Fosamax or after using Fosamax for several years. 

 

If you or someone you know is interested in filing a claim for legal compensation, we offer a free Case Evaluation online at our Drug Injury Law web site.

 

In the alternative, you can call our toll-free number, (800) 426-9535, to discuss a possible Fosamax case with attorney Tom Lamb.

 

______________________________________________________________________________

 

DrugInjuryLaw.com: Legal Information And News About Prescription Drug Side Effects _____________________________________________________________________________

Leave a Reply

Your email address will not be published. Required fields are marked *